These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus. Foulis AK J Pathol; 1987 Jul; 152(3):141-8. PubMed ID: 3309229 [TBL] [Abstract][Full Text] [Related]
4. [Etiology and pathogenesis of type I diabetes]. Ziegler AG Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631 [TBL] [Abstract][Full Text] [Related]
5. Specific therapeutic attempts in experimental and clinical type-I diabetes. Federlin K; Becker F Klin Wochenschr; 1990; 68 Suppl 21():38-43. PubMed ID: 2198389 [TBL] [Abstract][Full Text] [Related]
6. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases]. Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605 [TBL] [Abstract][Full Text] [Related]
7. [New findings on the pathogenesis of diabetes mellitus]. Keller U Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524 [TBL] [Abstract][Full Text] [Related]
9. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Sibley RK; Sutherland DE; Goetz F; Michael AF Lab Invest; 1985 Aug; 53(2):132-44. PubMed ID: 3894793 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus. Phillips BE; Giannoukakis N; Trucco M Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749 [TBL] [Abstract][Full Text] [Related]
11. Can insulin therapy delay or prevent insulin-dependent diabetes mellitus? Kakka R; Koda-Kimble MA Pharmacotherapy; 1997; 17(1):38-44. PubMed ID: 9017764 [TBL] [Abstract][Full Text] [Related]
12. [The prevention of insulin-dependent diabetes mellitus]. Loureiro MM; Duarte R; Boavida JM; Lisboa PE Acta Med Port; 1996; 9(10-12):353-60. PubMed ID: 9254534 [TBL] [Abstract][Full Text] [Related]
13. [The pathogenesis of type 1 diabetes mellitus]. Schönle EJ Ther Umsch; 1990 Jan; 47(1):15-21. PubMed ID: 2408178 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulation for the prevention of SPIDDM and LADA. Pozzilli P; Guglielmi C Ann N Y Acad Sci; 2006 Oct; 1079():90-8. PubMed ID: 17130536 [TBL] [Abstract][Full Text] [Related]
15. The role of immunotherapy in type I diabetes mellitus. Geffner ME; Lippe BM West J Med; 1987 Mar; 146(3):337-43. PubMed ID: 3554759 [TBL] [Abstract][Full Text] [Related]
16. [Immunosuppression in Type I diabetes mellitus]. Schönle EJ; Sizonenko PC; Spinas GA Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1225-7. PubMed ID: 2237051 [TBL] [Abstract][Full Text] [Related]
17. [Immuno- and regeneration therapy of recently diagnosed diabetes mellitus type I]. Huth E Klin Padiatr; 1985; 197(2):75-84. PubMed ID: 3157826 [TBL] [Abstract][Full Text] [Related]
18. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats. Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220 [TBL] [Abstract][Full Text] [Related]
19. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes? Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492 [TBL] [Abstract][Full Text] [Related]
20. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus. Tsirogianni A; Pipi E; Soufleros K Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]